ClinicalTrials.Veeva

Menu

Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy

P

Prostate Cancer Foundation of Chicago

Status and phase

Unknown
Phase 4

Conditions

Prostate Cancer

Treatments

Device: RapidStrand seeds for use with 18g needle
Device: ThinStrand

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study will investigate health related quality of life factors in patients undergoing low dose rate prostate brachytherapy. Patients will be randomized to Iodine-125 Thinstrand (for use with 20 g needles) or Rapidstrand (for use with standard 18 g needles). Urinary, bowel, sexual function and bother will be measured by the EPIC questionnaire at various time intervals.

Enrollment

240 estimated patients

Sex

Male

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically confirmed adenocarcinoma of the prostate, clinical stage T1c - T2b, N0, M0
  • Greater than or equal to 40 years of age
  • Low and Low- Intermediate Risk prostate cancer
  • Prostate volumes by TRUS ≤ 60 cc
  • I-PSS score < 25 (alpha blockers allowed)
  • Signed study-specific informed consent form prior to study entry

Exclusion criteria

  • Lymph node involvement (N1)
  • Evidence of distant metastases (M1)
  • Radical surgery for carcinoma of the prostate
  • Prior pelvic radiation
  • Major medical or psychiatric illness, which in the investigator's opinion would prevent completion of treatment and would interfere with follow- up or ability to complete questionnaires
  • Hip prosthesis
  • Inability or refusal to provide informed consent
  • Evidence of Previous TURP
  • Prior hormone therapy
  • Prior TURP

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

240 participants in 2 patient groups

Iodine-125 standard 18 g needle
Active Comparator group
Description:
Rapidstrand
Treatment:
Device: ThinStrand
Device: RapidStrand seeds for use with 18g needle
20 g needle
Active Comparator group
Description:
Thin Strand
Treatment:
Device: ThinStrand
Device: RapidStrand seeds for use with 18g needle

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems